Patient With Newly Diagnosed Diffuse Large B-Cell Non-Hodgkin Lymphoma: Considering Biosimilars

Drs. Jeffrey Crawford and Gary Lyman discuss the data and considerations that inform the potential use of biosimilars in a patient with newly diagnosed non-Hodgkin lymphoma.